GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Total Revenue Growth Rate (Future 3Y To 5Y Est) : N/A (As of Jun. 10, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Wantai Biological Pharmacy Enterprise Co Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.


Competitive Comparison of Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Biotechnology subindustry, Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



Beijing Wantai Biological Pharmacy Enterprise Co  (SHSE:603392) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Beijing Wantai Biological Pharmacy Enterprise Co Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Beijing Wantai Biological Pharmacy Enterprise Co's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Business Description

Traded in Other Exchanges
N/A
Address
No. 31, Science Park Road, Beiqing Road, Changping District, Beijing, CHN, 102206
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is an engaged in the research and development and production of biodiagnostic reagents and vaccines. The company produces chemiluminescence, nucleic acid, clinical biochemistry and other testing reagents and clinical inspection quality control products and vaccines. Its products include ELISA series, Colloidal gold series, Bole series, Confirmation series, Automatic blood group analyzer and reagent, Chemiluminescence series, Nucleic acid series, and Research Series.
Executives
Zhao Yi Yong senior management
Li Yi Min senior management
Zhao Ling Zhi Directors, senior managers
Qiu Zi Xin Directors, senior managers
Li Sha Yan senior management
Ye Xiang Zhong Directors, senior managers
Gao Yong Zhong Director

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Headlines

No Headlines